Fig. 3From: Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancerClinical outcomes acoorindg to the SUVmean change. Locoregional recurrence-free rate (a) and distant metastasis-free rate (b) of patients according to the mean standardized uptake value (SUVmean) reduction rate. Responders were patients with SUVmean reduction rates > 35%, while non-responders were patients with SUVmean reduction rates ≤35%Back to article page